Mar 302017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NJ – Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today the appointment of Eric J.=> Read more

Matinas BioPharma appoints Dr Eric Ende to its Board of Directors

From:: Matinas BioPharma appoints Dr Eric Ende to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: